Research / FCUV / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-19-002577 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.61% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-19.46% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
956.65% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 22th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
21.05% · OPTIONAL · VALID
Gross margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
32.92% · CORE · VALID
Operating margin 67th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
-117.14% · CORE · VALID
R&D intensity 0th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.40% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.85% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 5/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 74.62%
Current 8.61%
Delta -66.01% Cash Generation Increased
Previous -152.06%
Current -19.46%
Delta 132.61% Growth Increased
Previous 254.09%
Current 956.65%
Delta 702.56% Inventory Pressure Increased
Previous 18.72%
Current 21.05%
Delta 2.33% Margin Decreased
Previous 49.69%
Current 32.92%
Delta -16.77% Profitability Increased
Previous -184.56%
Current -117.14%
Delta 67.43% R And D Intensity Decreased
Previous 25.54%
Current 15.40%
Delta -10.15% Sbc Intensity Decreased
Previous 14.83%
Current 2.85%
Delta -11.98% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.